Synonyms
4-Bromo-2,5-dichlorophenyl dimethyl phosphorothionate; Brofene; Bromo-phos-methyl; Bromofos; Bromofos-methyl; Bromofosum [INN-Latin]; Bromovur; Brophene; Bruomophos [Russian]; Cela S 1942; Cx99; Drillzid; EL 400; ENT 27,162; Metabrom; Mexion; Monsanto CP 51969; Netal; Nexagan; Nexion; Nexion 40; Nexion 5G; Nexion LC40; O,O-Dimethyl O-(2,5-dichloro-4-bromophenyl) phosphorothioate; O,O-Dimethyl O-(2,5-dichloro-4-bromophenyl) thiophosphate; O,O-Dimethyl O-(4-bromo-2,5-dichlorophenyl) phosphorothioate; O,O-Dimethyl-O-(2,5-dichlor-4-bromphenyl)-thionophosphat [German]; O,O-Dimethyl-O-(2,5-dichloro-4-bromophenyl)phosphorothioate; O,O-Dimethyl-O-2,5-dichloro-4-bromophenyl phosphorothionate; O-(4-Brom-2,5-dichlor-phenyl)-O,O-dimethyl-monothiophosphat [German]; O-(4-Bromo-2,5-dichlorophenyl) O,O-dimethyl monothiophosphate; O-(4-Bromo-2,5-dichlorophenyl) O,O-dimethyl phosphorothioate; O-(4-Bromo-2,5-dicloro-fenil)-O,O-dimetil-monotiofosfato [Italian]; O-(4-Broom-2,5-dichloor-fenyl)-O,O-dimethyl-monothiofosfaat [Dutch]; OMS 658; OMS-658; Omexan; Phenol, 4-bromo-2,5-dichloro-, O-ester with O,O-dimethyl phosphorothioate; Phosphorothioic acid O-(4-bromo-2,5-dichlorophenyl) O,O-dimethyl ester; S 1942; S-1942; Sovinexion; Thiophosphate de O,O-dimethyle et de O-4-bromo-2,5-dichlorophenyle [French; [ChemIDplus] UN2783
Sources/Uses
Used as an insecticide and acaricide for fruit, vegetables, field crops, ornamentals, forestry, stored products, public health (i.e. flies and mosquitoes), household use, animal houses, and animal dips; [HSDB]
Comments
Depressed plasma cholinesterase was the only clinical effect found in applicators in a village in Africa; Shown to inhibit cholinesterase activity in high-dose feeding and dermal animal studies; Effects in a 100 day high-dose feeding study with rats include slow growth rates and minor degenerative damage to kidneys and liver; [HSDB] “The average of two baseline respective cholinesterase activity determinations three days apart, with no exposures to enzyme inhibiting pesticides for at least 30 days, is recommended for each worker prior to exposure to cholinesterase inhibitors because of large inter-individual differences in published baseline values. To be established at least once a year. Removal from workplace exposures is recommended until the cholinesterase activity returns to within 20% of baseline.” [TLVs and BEIs]